Intrinsic Edge Capital Management LLC Lantheus Holdings, Inc. Transaction History

Intrinsic Edge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $11.9 Million - $14.4 Million	144,182 Added 115.35%	269,182 $22.6 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $5.97 Million - $10.4 Million	125,000 New	125,000 $10.3 Million
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $13.3 Million - $18.6 Million	-215,944 Reduced 58.22%	154,962 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $1.16 Million - $1.52 Million	20,906 Added 5.97%	370,906 $24.5 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $8.5 Million - $19.8 Million	350,000 New	350,000 $19.4 Million

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.